QRONOTCdelisted

Qrons Inc.

Healthcare·Neurology·Pre-clinical
NeurologyInfectious Disease

Qrons Inc. (QRON): 3 pipeline candidates. Updated within the last hour.

6.0/10

BioSniper Score

3-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health10.0

D/E -1.00 · 0% dilution

Pipeline Maturity2.0

Lead: Preclinical

Pipeline Breadth5.9

3 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Qrons Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

—

Cash

$659

Quarterly Burn

—

Runway

—

Revenue

—

Pipeline (3 candidates)

DrugPhase
qs100Preclinical
qs200Preclinical
tellurium based compoundsPreclinical

Frequently asked questions

How many drug candidates are in Qrons Inc.'s pipeline?

Qrons Inc. (QRON) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Qrons Inc.'s lead drug candidate?

Qrons Inc.'s most advanced tracked candidate is qs100 (Preclinical) for Penetrating brain injuries.

Get the full picture on Qrons Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar